Trial Profile
A Study to Evaluate the Efficacy of Telaprevir or Boceprevir in Combination with Peginterferon plus Ribavirin in Hepatitis C Virus (HCV) genotype 1 Infected Patients with Severe Liver Fibrosis who were Nonresponder to Previous Peginterferon + Ribavirin Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Peginterferon (Primary) ; Ribavirin (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 14 Dec 2015 New trial record